Agastiya Biotech
Advertisement
Agastiya Biotech, based in Bonsall, CA, is a pioneering oncology company that utilizes systems biology, immunotherapy, and quantum biophysics to develop innovative cancer treatments. Its lead therapeutic, AB001, is a first-in-class, orally available small molecule with multiple synergistic mechanisms aimed at addressing various tumor mutations and enhancing cancer care.
AB001's unique profile includes pan-KRAS inhibition, PD-L1 immunomodulation, and cancer stem cell dissolution, showcasing no dose-limiting toxicities in Phase I trials. The company is also exploring anti-viral therapeutics and novel formulations for cancer treatment, demonstrating its commitment to breakthrough therapies in the oncology field.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement